Monetizing Science: Turning an Asset into Value through IPOs
PharmaTalkRadio16 Okt 2019

Monetizing Science: Turning an Asset into Value through IPOs

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
jss
liberal-halvtime
tomprat-med-gunnar-tjomlid
sinnsyn
rss-paradigmepodden
rekommandert
forskningno
smart-forklart
fjellsportpodden
villmarksliv
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
diagnose
tidlose-historier